Skip to main content
Log in

Butyric acid: Inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth

  • Original Articles
  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

Butyric acid has been shown to inhibit the growth of several established tumor cell lines and to induce either granulocytic or erythroid differentiation in different human and murine leukemic cell lines. The dose-dependent effect of butyric acid was testedin vitro on the clonal growth of granulocyte macrophage progenitors in 13 patients with chronic myeloid leukemia (CML) and compared with control bone marrow and peripheral blood responses.

The growth of myeloid progenitors from both healthy donors and non-leukemic and leukemic patients was almost completely inhibited by 1.0 mM butyric acid. At 0.5 mM butyric acid, inhibition of CML progenitors, both from chronic phase and blastic phase patients, was significantly greater (P < 0.01) than bone marrow from non-leukemic patients and peripheral blood controls. Butyric acid, a 4-carbon compound, was the most potent inhibitor of six short chain fatty acids tested on CML myeloid progenitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leder A, Leder R: Butyric acid as a potent inducer of erythroid differentiation in cultured erythroleukemic cells.Cell 5, 319 (1975).

    Article  PubMed  CAS  Google Scholar 

  2. Cioe L, McNab A, Hubbell H R, Meo P, Curtis P, Rovera G: Differential expression of the globin genes in human leukemia K562 cells induced to differentiate by hemin or butyric acid.Cancer Res 41, 237 (1981).

    PubMed  CAS  Google Scholar 

  3. Collins S J, Ruscetti F W, Gallagher R E, Gallo R C: Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds.Proc natn Acad Sci USA 75, 2458 (1978).

    Article  CAS  Google Scholar 

  4. Novogrodsky A, Rubin A L, Stenzel K H: A new class of inhibitors of lymphocyte mitogenesis: agents that induce erythroid differentiation in Friend leukemia cells.J Immun 124, 1892 (1980).

    PubMed  CAS  Google Scholar 

  5. Prasad K N, Sinha P K: Effect of sodium butyrate on mammalian cells in culture. A review.In Vitro 12, 125 (1976).

    Article  PubMed  CAS  Google Scholar 

  6. Tsao D, Morita A, Bella A Jr, Luu P, Kim Y S: Differential effects of sodium butyrate, dimethyl sulfoxide and retinoic acid on membrane-associated antigen, enzymes and glycoproteins of human rectal adenocarcinoma cells.Cancer Res 42, 1052 (1982).

    PubMed  CAS  Google Scholar 

  7. Dexter D L, Lev R, McKendall G R, Mitchell P, Calabres F: Sodium butyrate induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells.Histochem J 16, 137 (1984).

    Article  PubMed  CAS  Google Scholar 

  8. Reese D H, Gratzner H G, Block N L, Politano V A: Control of growth, morphology and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell.Cancer Res 45, 2308 (1985).

    PubMed  CAS  Google Scholar 

  9. Nordenberg J, Wasserman L, Beery E, Aloni D, Malik H, Stenzel K H, Novogrodsky A: Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide.Exp Cell Res 162, 77 (1986).

    Article  PubMed  CAS  Google Scholar 

  10. McIntyre L J, Kim Y S: Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumour cell lines.Eur J Cancer clin Oncol 20, 265 (1984).

    Article  PubMed  CAS  Google Scholar 

  11. Novogrodsky A, Dvir A, Ravid A, Shkolnik T, Stenzel K H, Rubin A L, Zaizov R: Effects of polar organic compounds on leukemic cells. Butyrate induced partial remission of acute myelogenous leukemia in a child.Cancer 51, 9 (1983).

    Article  PubMed  CAS  Google Scholar 

  12. Januszewicz E, Cooper I A, Bradley T R: Requirement for growth of human erythroid progenitors in nutrient agar.Am J Hemat 15, 207 (1983).

    Article  PubMed  CAS  Google Scholar 

  13. Boyd A W, Metcalf D: Induction of differentiation in HL-60 leukaemic cells: a cell cycle dependent all or none event.Leuk Res 8, 27 (1984).

    Article  PubMed  CAS  Google Scholar 

  14. Fischkoff S A, Condon M E: Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions.Cancer Res 45, 2065 (1985).

    PubMed  CAS  Google Scholar 

  15. Riggs M G, Whittaker R G, Neumann J R, Ingram V M:n-Butyrate causes histone modification in HeLa and Friend erythroleukemia cells.Nature 268, 462 (1977).

    Article  PubMed  CAS  Google Scholar 

  16. Kirshner J, Preisler H D:In vitro drug sensitivity studies of colony forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic phase patients and normal donors.Cancer Res 43, 6094 (1983).

    PubMed  CAS  Google Scholar 

  17. Rephaeli A, Rabizadah E, Nordenberg J, Kluska A, Prokocimer M, Rosenberg I, Novogrodsky A, Shaklai M: Effect of the differentiation inducers butyrate, retinoic acid and low dose cytosine arabinoside on leukemic cells of patients with acute nonlymphatic leukemia. Comparison ofin vitro andin vivo studies.Blood 68, 192a (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Januszewicz, E., Rabizadah, E., Novogrodsky, A. et al. Butyric acid: Inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth. Med. Oncol. & Tumor Pharmacother. 5, 259–263 (1988). https://doi.org/10.1007/BF03003194

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03003194

Key words

Navigation